{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nLong noncoding RNAs have emerged as pivotal players in the development and progression of hepatocellular carcinoma (HCC). In this context, SH3BP5‑AS1 is being evaluated for its contribution to HCC carcinogenesis. Although the study primarily outlines the objective to uncover the function and mechanism of SH3BP5‑AS1, its inclusion underscores a potential role in modulating cellular pathways that may drive tumor initiation and progression. This investigation raises the possibility that SH3BP5‑AS1 could serve as a novel biomarker or therapeutic target in HCC management, reflecting a growing interest in lncRNAs as key regulatory molecules in cancer biology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xinyang Zhao, Xinfeng Zhu, Chaowen Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SH3BP5-AS1 promotes hepatocellular carcinoma progression by sponging miR-6838-5p and activation of PTPN4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.205811"}], "href": "https://doi.org/10.18632/aging.205811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38761175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38761175"}]}]}]}